Impact of intermediate to high doses of methylprednisolone on mortality rate in patients with COVID‐19 pneumonia‐induced severe systemic inflammation

Autor: María Antonia Marco-Artal, Francisco Dolz-Sinisterra, María Luisa López-Grima, Ian López-Cruz, Ángel Atienza-García, Tomás Ripollés-González, Rosario Lopez-Estudillo, José Miguel Nogueira-Coito, Daniel Bautista-Rentero, Juan Vicente Llau-Pitarch, Ramón Romero-Serrano, Rafael Zaragoza-Crespo, Eva Martínez-Moragón, Emilio Garijo-Gómez, Mónica Climente-Martí, Oreto Ruiz-Millo

Publikováno v: International Journal of Clinical Practice

Introduction In addition to respiratory support needs, patients' characteristics to guide indication or timing of corticosteroid treatment in COVID‐19 patients are not completely established. This study aimed to evaluate the impact of methylprednis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be079f1de44c136a04670ddbf7767177
https://doi.org/10.1111/ijcp.14479

Patient and health professional satisfaction with an interdisciplinary patient safety program

Autor: Mónica Climente-Martí, Oreto Ruiz-Millo, José Ramón Navarro-Sanz

Publikováno v: INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname

Background Measuring humanistic outcomes is an important component of valuating healthcare services. There is a paucity of data on satisfaction with pharmacist implemented clinical services in long-term care settings. Objective To evaluate patient an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11aed6f5a792d30e7e8f0a32c0de7e31
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3057

Comparative cost-effectiveness of bevacizumab-irinotecan-fluorouracil versus irinotecan-fluorouracil in first-line metastatic colorectal cancer

Autor: N. Víctor Jiménez-Torres, A. Sendra-García, Oreto Ruiz-Millo, Asunción Albert-Marí

Publikováno v: Journal of Oncology Pharmacy Practice. 20:341-350

Purpose To evaluate the cost-effectiveness of the addition of bevacizumab to the irinotecan-fluorouracil (Douillard regimen-CPT-FUFA-) in first-line treatment of metastatic colorectal cancer in a single-institution population. Methods Controlled, non

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cfdfc605b3c29abeb99fea68d6be27c
https://doi.org/10.1177/1078155213508437